Author: Helitra.com

BioCardia shares climb as it gets FDA clearance for its Morph DNA product family Source: Seekingalpha

Nuvectis gains on FDA’s orphan drug designation for cancer therapy Source: Seekingalpha

Neurocrine upped to overweight by Piper, sees ‘568 as still viable Source: Seekingalpha

CooperCompanies hits 52-week high on Q3 beat and guidance Source: Seekingalpha

Lifecore CFO John Morberg to depart, Ryan Lake to succeed Source: Seekingalpha

J&J submits FDA application for myasthenia gravis drug nipocalimab Source: Seekingalpha

Catalent ends FY24 on a strong note ahead of Novo buyout Source: Seekingalpha

Brookfield in talks with sovereign funds over Grifols bid: report Source: Seekingalpha

Eli Lilly’s Zepbound price cut comes with shocker for those on patient assistance Source: Seekingalpha

Imunon files to sell up to 5M shares Source: Seekingalpha